Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kristian Reich currently holds 2,824,551 shares of MoonLake Immunotherapeutics (MLTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristian Reich has been a net seller of MLTX stock. They have purchased $0 and sold $17.3M worth of shares.
Kristian Reich's most recent insider trade was on Jun 17, 2026, when they sold 50,000 shares at $19.43 per share.
Kristian Reich serves as Executive at MoonLake Immunotherapeutics (MLTX). They have executed 31 insider transactions totaling $17.3M over their tenure at the company.
Kristian Reich holds the position of Executive at MoonLake Immunotherapeutics, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Kristian Reich has shown a selling trading pattern, with $0 in total purchases and $17.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kristian Reich was on Dec 8, 2025, when they sold $2.0M worth of MLTX shares. This transaction involved 130,000 shares at $15.08 per share.
Kristian Reich currently owns 2,824,551 shares of MoonLake Immunotherapeutics (MLTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kristian Reich's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kristian Reich has 31 Form 4 filings on record as an insider at MoonLake Immunotherapeutics.
Set alerts for Kristian Reich and 40,000+ other insiders.